Clinical Trials
2 trialsNCT01967758 2018-08-17
Phase I Study of Safety and Immunogenicity of ADU-623
Providence Health & Services
Phase 1 Completed
NCT00445497 2013-08-12
Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia
National Cancer Institute (NCI)
Phase 3 Unknown